A Randomized Controlled Trial Comparing Percutaneous CT-Guided Biopsy and Shape-Sensing Robotic-Assisted Bronchoscopy

← catalyst calendar

NCT07761351 · readout in 620 d

Sponsored by Intuitive Surgical (industry) · ISRG — their whole pipeline →.

Phase

Phase 4

Status

Not yet recruiting

Study type

Interventional

Design

Randomized · None · Diagnostic

Enrollment

550estimated

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis

Date

Filed

Basis

What it is

Start

2026-08-31

estimated

When the study began enrolling

Primary completion

2028-04-30

estimated

The date the last participant is measured for the primary outcome — the readout window

Study completion

2029-04-30

estimated

The whole study's end, after follow-up

First posted

2026-08-12

actual

When this record first appeared on the registry

Results posted

—

When the sponsor posted results to the registry

Record updated

2026-08-12

actual

The sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Conditions

Lung Cancer (Diagnosis)
Lung Nodule

Interventions

Procedure: Shape-Sensing Robotic-Assisted Bronchoscopy with Cone-Beam CT (ssRAB with CBCT) — also filed as ssRAB, Ion endoluminal system
Procedure: CT-guided percutaneous lung nodule biopsy — also filed as Transthoracic Needle Aspiration (TTNA), Transthoracic Needle Biopsy (TTNB)

Primary outcomes

what the primary-completion date above is the date OF

Diagnostic Efficacy of the Assigned Biopsy Procedure

measured At the index procedure

Peri-Procedural Pneumothorax Rate

measured From procedure to 7 days (or until subsequent intervention, whichever occurs first).

Permalink · ISRG's whole pipeline · Catalyst calendar · Every registered study · What changed